A label-free DNA aptamer-based impedance biosensor for the detection of E. coli outer membrane proteins

A label-free DNA aptamer-based impedance biosensor for the detection of E. coli outer membrane proteins (OMPs) was developed. Two single stranded DNA sequences were tested as recognition elements and compared. The aptamer capture probes were immobilized, with and without 6-mercapto-1-hexanol (MCH) on a gold electrode. Each step of the modification process was characterized by Faradaic impedance spectroscopy (FIS). A linear relationship between the electron-transfer resistance (Ret) and E. coli OMPs concentration was demonstrated in a dynamic detection range of 1 × 10−7–2 × 10−6 M. Moreover, the aptasensor showed selectivity despite the presence of other possible water contaminates and could be regenerated under low pH condition. The developed biosensor shows great potential to be incorporated in a biochip and used for in situ detection of E. coli OMPs in water samples.

Label-free DNA detection of hepatitis C virus based on modified conducting polypyrrole films at microelectrodes and atomic force microscopy tip-integrated electrodes

We present a new strategy for the label-free electrochemical detection of DNA hybridization for detecting hepatitis C virus based on electrostatic modulation of the ion-exchange kinetics of a polypyrrole film deposited at microelectrodes. Synthetic single-stranded 18-mer HCV genotype-1-specific probe DNA has been immobilized at a 2,5-bis(2-thienyl)-N-(3-phosphoryl-n-alkyl)pyrrole film established by electropolymerization at the previously formed polypyrrole layer. HCV DNA sequences (244-mer) resulting from the reverse transcriptase-linked polymerase chain reaction amplification of the original viral RNA were monitored by affecting the ion-exchange properties of the polypyrrole film. The performance of this miniaturized DNA sensor system was studied in respect to selectivity, sensitivity, and reproducibility. The limit of detection was determined at 1.82 x 10(-21) mol L-1. Control experiments were performed with cDNA from HCV genotypes 2a/c, 2b, and 3 and did not show any unspecific binding. Additionally, the influence of the spacer length of 2,5-bis(2-thienyl)-N-(3-phosphoryl-n-alkyl)pyrrole on the behavior of the DNA sensor was investigated. This biosensing scheme was finally extended to the electrochemical detection of DNA at submicrometer-sized DNA biosensors integrated into bifunctional atomic force scanning electrochemical microscopy probes. The 18-mer DNA target was again monitored by following the ion-exchange properties of the polypyrrole film. Control experiments were performed with 12-base pair mismatched sequences.

Label-free DNA detection based on modified conducting polypyrrole films at microelectrodes

A label-free electrochemical detection method for DNA hybridization based on electrostatic modulation of the ion-exchange kinetics of a polypyrrole film deposited at microelectrodes is reported. Synthetic single-stranded 27-mer oligonucleotides (probe) have been immobilized at 2,5-bis(2-thienyl)-N-(3-phosphorylpropyl)pyrrole film formed by electropolymerization on the previously formed polypyrrole layer. The 27- or 18-mer target oligonucleotides were monitored via the electrochemically driven anion exchange of the inner polypyrrole film. The performance of the miniaturized DNA biosensor system was studied in respect to selectivity, sensitivity, reproducibility, and regeneration of the sensor. Control experiments were performed with a noncomplementary target of 27-mer DNA and 12 base-pair mismatched 18-mer sequences, respectively, and did not show any unspecific binding. Under optimized experimental conditions, the label-free electrochemical biosensor enabled the detection limits of 0.16 and 3.5 fmol for the 18- and 2 7-mer DNA strand, respectively. Furthermore, we demonstrate reusability of the electrochemical DNA biosensor after successful recovery of up to 100% of the original signal by regenerating the DNA label-free electrode with 50 mM HCl at room temperature.

Structural Polymorphism of the Nucleosomal DNA and Implications for Protein Binding

A nucleosome forms a basic unit of the chromosome structure. A biologically relevant question is how much of the nucleosomal conformational space is accessible to protein-free DNA, and what proportion of the nucleosomal conformations are induced by bound histones. To investigate this, we have analysed high resolution xray crystal structure datasets of DNA in protein-free as well as protein-bound forms, and compared the dinucleotide step parameters for the two datasets with those for high resolution nucleosome structures. Our analysis shows that most of the dinucleotide step parameter values for the nucleosome structures lie within the range accessible to protein-free DNA, indirectly indicating that the histone core plays more of a stabilizing role. The nucleosome structures are observed to assume smooth and nearly planar curvature, implying that ‘normal’ B-DNA like parameters can give rise to a curved geometry at the gross structural level. Different nucleosome

Small local variations in B-form DNA lead to a large variety of global geometries which can accommodate most DNA-binding protein motifs

An important question of biological relevance is the polymorphism of the double-helical DNA structure in its free form, and the changes that it undergoes upon protein-binding. We have analysed a database of free DNA crystal structures to assess the inherent variability of the free DNA structure and have compared it with a database of protein-bound DNA crystal structures to ascertain the protein-induced variations.

Flourescent Switch Constructed Based on Hemin-Sensitive Anionic Conjugated Polymer and Its Applications in DNA-Related Sensors

Here, a fluorescent switch is constructed combining hemin, hemin aptamer, and a newly synthesized anionic conjugated polymer (ACP), poly(9,9-bis(6'-phosphate-hexyl) fluorenealt-1,4-phenylene) sodium salt (PFHPNa/PFP). In the "off-state", the fluorescence of PFP is sensitively quenched by hemin, with a high K-sv value of similar to 10(7). While in the "on-state", the formation of the aptamer/hemin complex recovers the fluorescence intensity. The fluorescent switch is sensitive and selective to hemin. To testify the universality and practicality of the fluorescent switch, a series of label-free DNA-related sensing platforms are developed, containing three DNA sensing strategies and one ATP recognition strategy. The fluorescent switch developed is simple, sensitive, and universal, which extends applications of the anionic conjugated polymers.

DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexescontaining heteroaromatic ligands

Four ruthenium(II) complexes with the formula [Ru(eta(5)-C(5)H(5))(PP)L][CF(3)SO(3)], being (PP = two triphenylphosphine molecules), L = 1-benzylimidazole, 1; (PP = two triphenylphosphine molecules), L = 2,2'bipyridine, 2; (PP = two triphenylphosphine molecules), L = 4-Methylpyridine, 3; (PP = 1,2-bis(diphenylphosphine) ethane), L = 4-Methylpyridine, 4, were prepared, in view to evaluate their potentialities as antitumor agents. The compounds were completely characterized by NMR spectroscopy and their crystal and molecular structures were determined by X-ray diffraction. Electrochemical studies were carried out giving for all the compounds quasi-reversible processes. The images obtained by atomic force microscopy (AFM) suggest interaction with pBR322 plasmid DNA. Measurements of the viscosity of solutions of free DNA and DNA incubated with different concentrations of the compounds confirmed this interaction. The cytotoxicity of compounds 1234 was much higher than that of cisplatin against human leukemia cancer cells (HL-60 cells). IC(50) values for all the compounds are in the range of submicromolar amounts. Apoptotic death percentage was also studied resulting similar than that of cisplatin. (C) 2010 Elsevier Inc. All rights reserved.

Propidium monoazide (PMA) and ethidium bromide monoazide(EMA) improve DNA array and high-throughput sequencing ofporcine reproductive and respiratory syndrome virus identification

Pan-viral DNA array (PVDA) and high-throughput sequencing (HTS) are useful tools to identify novel viruses of emerging diseases. However, both techniques have difficulties to identify viruses in clinical samples because of the host genomic nucleic acid content (hg/cont). Both propidium monoazide (PMA) and ethidium bromide monoazide (EMA) have the capacity to bind free DNA/RNA, but are cell membrane-impermeable. Thus, both are unable to bind protected nucleic acid such as viral genomes within intact virions. However, EMA/PMA modified genetic material cannot be amplified by enzymes. In order to assess the potential of EMA/PMA to lower the presence of amplifiable hg/cont in samples and improve virus detection, serum and lung tissue homogenates were spiked with porcine reproductive and respiratory virus (PRRSV) and were processed with EMA/PMA. In addition, PRRSV RT-qPCR positive clinical samples were also tested. EMA/PMA treatments significantly decreased amplifiable hg/cont and significantly increased the number of PVDA positive probes and their signal intensity compared to untreated spiked lung samples. EMA/PMA treatments also increased the sensitivity of HTS by increasing the number of specific PRRSV reads and the PRRSV percentage of coverage. Interestingly, EMA/PMA treatments significantly increased the sensitivity of PVDA and HTS in two out of three clinical tissue samples. Thus, EMA/PMA treatments offer a new approach to lower the amplifiable hg/cont in clinical samples and increase the success of PVDA and HTS to identify viruses.

Coagglutination for viral DNA preparation of canine parvovirus for molecular diagnosis

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Tethered DNA scaffolds on optical sensor platforms for detection of hipO gene from Campylobacter jejuni

DNA biosensors have gained increased attention over traditional diagnostic methods due to their fast and responsive operation and cost-effective design. The specificity of DNA biosensors relies on single-stranded oligonucleotide probes immobilized to a transduction platform. Here, we report the development of biosensors to detect the hippuricase gene (hipO) from Campylobacter jejuni using direct covalent coupling of thiol- and biotin-labeled single-stranded DNA (ssDNA) on both surface plasmon resonance (SPR) and diffraction optics technology (DOT, dotLab) transduction platforms. This is the first known report of the dotLab to detect targeted DNA. Application of 6-mercapto-1-hexanol as a spacer thiol for SPR gold surface created a self-assembled monolayer that removed unbound ssDNA and minimized non-specific detection. The detection limit of SPR sensors was shown to be 2.5 nM DNA while dotLab sensors demonstrated a slightly decreased detection limit of 5.0 nM (0.005 μM). It was possible to reuse the SPR sensor due to the negligible changes in sensor sensitivity (∼9.7 × 10 -7 ΔRU) and minimal damage to immobilized probes following use, whereas dotLab sensors could not be reused. Results indicated feasibility of optical biosensors for rapid and sensitive detection of the hipO gene of Campylobacter jejuni using specific ssDNA as a probe. © 2011 Elsevier B.V.

In vivo- und In vitro-DNA-Verpackung in virusähnliche Partikel des Humanen Papillomvirus Typ 33

Die Rolle der DNA-Bindungsdomäne der Kapsidproteine L1 und L2 humaner Papillomviren (HPV) wird bezüglich der in vitro DNA-Verpackung kontrovers diskutiert und ist für die in vivo DNA-Verpackung noch ungeklärt. Ich konnte zeigen, dass die L1 Proteine der HPV Typen 16, 18 und 33 DNA binden, nicht aber das HPV33 L2 Protein. Die DNA-Bindungsdomäne habe ich auf die letzten sieben Aminosäuren des Carboxyterminus eingegrenzt. In Funktionsanalysen zeigte ich, dass die DNA-Bindungsdomäne des L1 Proteins für den Einschluss von Markerplasmid DNA in Kapside in einem in vivo Ansatz essentiell ist, nicht aber für eine in vitro DNA-Verpackung. Das L2 Protein, das in Kapside eingebaut wurde, denen die L1 DNA-Bindungsdomäne fehlte, konnte die DNA-Verpackung nicht aufrechterhalten.Zusätzlich habe ich die Infektiösität in vitro und in vivo hergestellter DNA-haltiger Kapside (Pseudovirionen) verglichen. Dabei konnte ich zeigen, dass in vivo gewonnene Pseudovirionen, die DNA in Form von Chromatin enthalten, bis zu fünffach infektiöser sind als Pseudovirionen, die in vitro hergestellt wurden und histonfreie DNA enthalten. Biochemische und strukturelle Unterschiede konnten zwischen den zwei Arten von Pseudovirionen nicht festgestellt werden. Chromatin scheint demzufolge die Infektiösität der Pseudovirionen zu verstärken.

Untersuchungen zum Mechanismus der zellulären und zellfreien DNA-Schädigung durch photosensibilisierende Arzneistoffe

Einige Arzneistoffe verursachen unter dem Einfluss von Sonnenlichtstrahlung folgenschwere Hautveränderungen. In der Arbeit wurden für sechs Photosensibilisatoren erstmals „Fingerabdrücke“ des zellfreien und zellulären photoinduzierten DNA Schadens in Form von Schadensprofilen erstellt. Untersucht wurden das Phenothiazin Chlorpromazin, sowie dessen Derivate 2-Hydroxypromazin, Chlorpromazinsulfoxid und Promazin; die Fluorchinolone Ciprofloxacin und Lomefloxacin; sowie Doxycyclin und Methylenblau unter Bestrahlung mit künstlich erzeugtem Sonnenlicht. Neben Strangbrüchen in der DNA konnten durch den Einsatz von spezifischen DNA-Reparaturendonukleasen als Sonden die Mengen an oxidativen Purinmodifikationen, oxidative Pyrimidinmodifikationen und abasische Stellen bestimmt werden. Durch Verwendung von modulierenden Zusätzen wurde die Beteiligung von reaktiven Sauerstoffspezies überprüft. Besonders bei den Phenothiazinen zeigten sich Besonderheiten hinsichtlich der DNA-Schädigung. Promazin induziert unter Photoaktivierung, vermutlich über einen reduktiven Angriff an der DNA, eine hohe Anzahl sonst selten beobachteter Läsionen, nämlich abasischen Stellen und Dihydropyrimidine. Photoaktiviertes Chlorpromazin konnte in Zellen unerwarteterweise wahrscheinlich über die Reaktion von Photolyseprodukten mit einem endogenen Chromophor sonnenlichtinduzierte oxidative DNA-Modifikationen verhindern. Eine Schädigung zellfreier DNA fand nur statt, wenn der Photosensibilisator im Überschuss gegenüber den DNA-Basenpaaren vorlag, vermutlich weil ansonsten die Photolyse des Chlorpromazins durch Interkalation in die DNA verhindert wurde. Fluorchinolone zeigten eine starke Generierung von DNA-Strangbrüchen in Zellen, welche möglicherweise auf photoinduzierte Reaktionen der Arzneistoffe mit der eukaryotischen Topoisomerase zurückzuführen ist. Die Korrelation der gemessenen DNA-Schäden mit der Mikrokerninduktion führte zu der Annahme, dass besonders abasische Stellen bei der Entstehung von Mikrokernen eine Rolle spielen könnten.

Freisetzung von frei zirkulierender DNA unter einer Fahrradergometrie bei Straßenradfahrern

Ziel dieser Studie war es zu untersuchen, ob die unter Belastung vorliegenden Anstiege plasmatischer zellfreier DNA über den Mechanismus der NETose zu erklären sind. Zudem sollte die Assoziation von zellfreier DNA und leistungsphysiologischen Parametern geklärt werden. Anhand eines Stufenprotokolls wurden Straßenradfahrer belastet und durch Blutuntersuchungen auf DNA, MPO, Elastase sowie Leistungsphysiologie untersucht. Anhand der Ergebnisse kann die Herkunft der DNA aus NETs nicht bewiesen werden. Die Neutrophilen Granulozyten zeigen eine Degranulationsreaktion, die aber nicht parallel mit den DNA-Anstiegen verläuft. Leitsungsphysiologisch war auffällig, dass die absolute Leistung mit der DNA korreliert sowie Parameter des Herzkreislaufsystems ebenfalls ähnliche ansteigen wie die DNA im Blut.

Prospective study of fetal DNA in serum and disease activity during pregnancy in women with inflammatory arthritis

OBJECTIVE: Rheumatoid arthritis (RA) usually improves during pregnancy and recurs postpartum. Fetal cells and cell-free DNA reach the maternal circulation during normal pregnancy. The present study investigated dynamic changes in levels of fetal DNA in serum from women with RA and inflammatory arthritis during and after pregnancy to test the hypothesis that the levels of circulating fetal DNA correlate with arthritis improvement. METHODS: Twenty-five pregnant patients were prospectively studied. A real-time quantitative polymerase chain reaction panel targeting unshared, paternally transmitted HLA sequences, a Y chromosome-specific sequence, or an insertion sequence within the glutathione S-transferase M1 gene was used to measure cell-free fetal DNA. Results were expressed as fetal genomic equivalents per milliliter (gE/ml) of maternal serum. Physical examinations were conducted during and after pregnancy. RESULTS: Levels of fetal DNA in women with improvement in or remission of arthritis were higher than those in women with active disease, especially in the third trimester. Overall, an inverse relationship between serum fetal DNA levels and disease activity was observed (P < 0.001). Serum fetal DNA increased with advancing gestation, reaching median levels of 24 gE/ml (range 0-334), 61 gE/ml (range 0-689), and 199 gE/ml (range 0-2,576) in the first, second, and third trimesters, respectively, with fetal DNA clearance observed postpartum. Arthritis improvement was initially noted in the first trimester for most patients, increased further or was sustained with advancing gestation, and was active postpartum. CONCLUSION: Changes in serum fetal DNA levels correlated with arthritis improvement during pregnancy and recurrence postpartum. Immunologic mechanisms by which pregnancy might modulate RA activity are described.